MONTRUCCHIO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.023
EU - Europa 3.371
AS - Asia 1.160
SA - Sud America 28
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 8.620
Nazione #
US - Stati Uniti d'America 3.947
CN - Cina 828
IT - Italia 697
DK - Danimarca 437
IE - Irlanda 405
SE - Svezia 345
UA - Ucraina 318
DE - Germania 282
FR - Francia 268
FI - Finlandia 211
KR - Corea 175
GB - Regno Unito 132
PL - Polonia 92
AT - Austria 68
VN - Vietnam 60
CA - Canada 58
BE - Belgio 22
RU - Federazione Russa 19
IN - India 18
JP - Giappone 16
PT - Portogallo 16
ES - Italia 14
SN - Senegal 14
CH - Svizzera 13
NL - Olanda 12
TH - Thailandia 11
BR - Brasile 10
CO - Colombia 10
PH - Filippine 10
MX - Messico 9
AU - Australia 7
RO - Romania 6
SG - Singapore 6
EU - Europa 5
HK - Hong Kong 5
TW - Taiwan 5
UZ - Uzbekistan 5
HT - Haiti 4
ID - Indonesia 4
SA - Arabia Saudita 4
TR - Turchia 4
A1 - Anonimo 3
CU - Cuba 3
NG - Nigeria 3
UY - Uruguay 3
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
DM - Dominica 2
HR - Croazia 2
IL - Israele 2
LU - Lussemburgo 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 8.620
Città #
Ann Arbor 676
Beijing 618
Chandler 533
Dublin 402
Jacksonville 234
Villeurbanne 184
Torino 182
Dearborn 181
Ashburn 161
Wilmington 150
Princeton 143
Houston 135
Fairfield 134
Medford 118
Nyköping 117
Warsaw 92
Woodbridge 70
Vienna 66
Milan 61
Seattle 58
Boston 56
New York 50
Cambridge 45
Dong Ket 44
Fremont 44
Pisa 37
Turin 33
Hefei 31
Boardman 30
Guangzhou 30
Redwood City 27
Munich 25
San Mateo 24
Toronto 24
Verona 23
Washington 23
Brussels 19
Shanghai 18
Nanjing 15
Falls Church 14
Norwalk 14
Chicago 12
Detroit 12
Kunming 12
Buffalo 11
Montréal 10
Palaiseau 10
San Diego 10
Grafing 9
Nanchang 9
Hangzhou 8
Lachine 8
Rome 8
Alessandria 7
Florence 7
Mountain View 7
Ottawa 7
Perugia 7
Trieste 7
Jinan 6
Upper Marlboro 6
Xian 6
Zhengzhou 6
Bologna 5
Chengdu 5
Düsseldorf 5
Hebei 5
Mexico City 5
Modena 5
Palermo 5
Pavia 5
Shenyang 5
Taipei 5
Teresina 5
Tokyo 5
Auburn Hills 4
Baotou 4
Bari 4
Central District 4
Fiorano Modenese 4
Fuzhou 4
Helsinki 4
Madrid 4
Nürnberg 4
Padova 4
Phoenix 4
Port-au-Prince 4
Saint Petersburg 4
Santa Flavia 4
Silver Spring 4
Wuhan 4
Bengaluru 3
Catania 3
Chongqing 3
Edinburgh 3
Ferrara 3
Havana 3
Lappeenranta 3
Lausanne 3
London 3
Totale 5.277
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 401
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 292
Bleeding prevalence and transfusion requirement in patients with thrombocytopenia in the emergency department 284
Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level 232
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. 218
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing 213
THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study Claudio Moretti 209
Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis 208
Resistance to thromboembolism in PI3-K gamma-deficient mice 200
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease 187
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 174
Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis. 170
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 165
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 152
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 141
Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors. 127
AISF position paper on HCV in immunocompromised patients 118
Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis 117
Effect of cytokines on the cytoskeleton of resident glomerular cells. 115
Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: Expression and prognostic significance 109
Platelets and multi-organ failure in sepsis 108
[Physiopathological mechanisms in the natural history of the atherosclerotic plaque] 104
Elevated thrombopoietin in plasma of burned patientswithout and with sepsis enhances platelet activation 102
May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? 99
Thrombopoietin as early biomarker of disease severity in patients with acute pancreatitis 97
Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes 96
Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum 96
Thrombopoietin contributes to enhanced platelet activation in cigarette smokers 91
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 90
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. 84
Effect of platelet activating factor on guinea pig papillary muscle. 79
Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 78
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 78
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 77
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 76
Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 75
Alterazioni immunologiche in corso di uremia cronica. 75
Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. 75
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. 74
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. J Chromatogr B Biomed Appl. 72
Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. 70
THROMBOPOIETIN MAY CONTRIBUTE TO VENTILATOR-INDUCED LUNG INJURY 70
Thrombopoietin (TPO) Contributes to Platelet Activation in Human Diseases 69
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 69
Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 68
The role of platelet-activating factor in experimental immune complex pathology 66
In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 65
Release of platelet-activating factor in systemic lupus erythematosus. 64
Detection of platelet-activating factor in plasma of patients with streptococcal nephritis. 64
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. 64
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. 62
Effect of platelet-activating factor (PAF) on human cardiac muscle. 61
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. 61
Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. 60
Septic shock--the unravelling of molecular mechanisms. 59
IN VITRO OXYTOCIC ACTIVITY OF PLATELET-ACTIVATING FACTOR OH HUMAN MYOMETRIUM 59
The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 59
Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from noninfectious systemic inflammatory response syndrome at emergency department admission: A multicenter prospective study 59
Thrombopoietin contributes to enhanced platelet activation in patients with type 1 diabetes mellitus 59
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. 58
Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. 58
Prostacyclin inhibits the platelet-dependent effects of platelet-activating factor in the rabbit isolated heart. 58
Role of platelet-activating factor in cardiovascular pathophysiology. 57
Involvement of thrombopoietin in the development of organ injury in a mouse model of cecal ligation and puncture-induced sepsis 57
Isolated radiation-induced mitral stenosis: a yet undescribed valvulopathy 55
Release of Platelet activating factor (PAF) from ischemic reperfused rabbit heart 51
Platelet-activating factor and angiogenesis. 51
Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina 51
In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. 50
Immunopathology and progression of experimental renal disease. 49
Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome 49
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 48
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 47
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 47
Effects of heparin and its desulfated derivates on leukocyte-endothelial adhesion 46
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. 45
Role of platelet-activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. 45
Platelet-activating factor contracts human myometrium in vitro. 44
Protective effect of Verapamil on the cardiac and circulatory alterations induced by Platelet activating factor 43
Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors. 42
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases 42
Potential angiogenic role of platelet-activating factor in human breast cancer. 41
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. 41
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 41
Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions 40
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 40
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. 40
Regulation of polymorphonuclear cell activation by thrombopoietin. 40
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart 40
Role of platelet-activating factor in hypotension andplatelet activation induced by infusion of thrombolytic agents in rabbits. 38
Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. 37
La sepsi e lo shock settico. 37
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 36
Platelet activating factor is produced during infectious peritonitis in CAPD patients 36
Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor andP-selectin. 35
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 35
Effects of recombinant human megakaryocyte growth and development factor on platelet activation. 35
In vitro oxytocic activity of platelet-activating factor on human myometrium. 34
Experimental acute pancreatitis induced by platelet activating factor in rabbits. 34
Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. 33
Totale 8.572
Categoria #
all - tutte 23.396
article - articoli 0
book - libri 0
conference - conferenze 562
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019207 0 0 0 0 0 0 0 0 0 49 121 37
2019/20201.566 25 35 97 59 131 263 225 122 140 149 182 138
2020/20211.067 96 58 73 38 75 53 130 53 140 127 69 155
2021/20221.465 98 78 77 133 66 93 178 105 72 101 202 262
2022/20231.671 216 119 43 139 137 440 124 105 209 22 82 35
2023/2024493 102 105 49 22 40 105 21 30 2 17 0 0
Totale 9.058